z-logo
open-access-imgOpen Access
CXCR4-Antagonist: Plerixafor verbessert die Mobilisierung in der autologen hämatopoetischen Stammzelltransplantation
Author(s) -
Bertrand Coiffier,
Cornelius F. Waller,
Semiglazov Vf,
Sergei Tjulandin,
Dmitry Bentsion,
Stephen Chan,
Rodeina Challand,
Kun Wang,
Zhen Chen,
Laura Kahmann,
Ulrich Beyer,
Grit Mehlhorn,
Falk C. Thiel,
Vratislav Strnad,
Peter A. Fasching,
Michael P. Lux,
Beibei Zhang,
Junxue Wang,
Wensheng Xu,
Lei Wang,
Ni Wu,
Michael Stamatakos,
Charikleia Stefanaki,
Konstantinos Kontzoglou,
Stavroula Masouridi,
George H. Sakorafas,
Michael Safioleas,
Martin Fehr,
Roger von Moos,
Markus Furrer,
Richard Cathomas,
Karel Krejčí,
Tomáš Tichý,
Pavel Hořák,
Hana Ciferská,
Marián Hajdúch,
Josef Srovnal,
Radek Trojanec,
Michaela Zezulová,
Miloslava Zlevorová,
Lucie Kalinová,
J Zadražil,
RalfDieter Hofheinz,
SalahEddin AlBatran,
Karsten Ridwelski,
Christian Görg,
Klaus Wehle,
M. Birth,
Sebastian Fetscher,
Harald Scheiber,
Nadine Lukan,
Florian Lordick,
Wenkang Liu,
Xiang-Yang Jiang,
Jian-Kang Ren,
Zhenxi Zhang
Publication year - 2010
Publication title -
onkologie
Language(s) - German
Resource type - Journals
eISSN - 1423-0240
pISSN - 0378-584X
DOI - 10.1159/000321429
Subject(s) - plerixafor , cxcr4 antagonist , medicine , cxcr4 , chemokine , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom